First MR Conditional Pacemaker Portfolio in the US with Single- and Dual-Chamber Pacemakers LAKE OSWEGO, Oregon,—BIOTRONIK, a leading manufacturer of cardiovascular medical devices, announced today ...
New pacemakers models Effecta and Estella plus new feature Vp Suppression complete the Evia family LAKE OSWEGO, Ore. & BERLIN--(BUSINESS WIRE)-- BIOTRONIK, a leading manufacturer of implantable ...
BERLIN, March 24, 2026 /PRNewswire/ -- BIOTRONIK today announced the initiation of its global pivotal study evaluating the LivIQ leadless pacemaker system. This next-generation single‑device solution ...
Biotronik is looking to get the FDA's approval for a line of MRI-safe pacemakers--courtesy of Biotronik The FDA approved a clinical trial of Biotronik's proMRI pacemaker, a device designed to operate ...
Hosted on MSN
BIOTRONIK begins trial of LivIQ pacemaker system
BIOTRONIK has commenced its global pivotal trial assessing the LivIQ leadless pacemaker system, a next-generation single device solution intended for delivering atrioventricular (AV) synchrony through ...
BIOTRONIK continues to enrich its high quality product portfolio with the launch of the new external pacemakers. Reocor offers complete reliability in emergencies and temporary patient care, setting a ...
BIOTRONIK ProMRI ® pacing system portfolio gives patients more access to MRI scanning and physicians more options with single and dual chamber pacemaker systems BERLIN & NICE, France--(BUSINESS WIRE)- ...
LAKE OSWEGO, Ore.-- (BUSINESS WIRE)--BIOTRONIK, a leading manufacturer of cardiovascular medical devices, announced today that the Food and Drug Administration (FDA) has granted approval for its ...
International BIO-LivIQ Study Will Generate Evidence for Global LivIQ Leadless Pacemaker Approvals Far-Field Sensing and AV-Synchronous Pacing Performance Will be Validated by Real World Clinical Data ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results